Supervisor: Dr Amanda W. Kijas ( and Prof. Alan Rowan

Death due to haemorrhage (bleeding) is a preventable death. Yet 30-40% of people in a civilian setting die as a result of bleeding to death. In a military setting 90% of casualties with potentially survivable injuries die due to haemorrhage. This project will specifically target this clinical need, through the design, construction and testing of this portable efficacious haemostatic agent/dressing to control bleeding. We are employing potent snake venom proteins to bring about rapid and stable blood clot formation in combination with biomaterials to target specific wound types.

Research Group

Rowan Group


Efficacious haemostatic agent, snake venom, proteins, biomedical, biochemistry, biomaterials